Have your own idea? Try our Stock Screener
UPDATED Apr 16, 2025
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €6.70 | 16.5% | -44.2% | €188.2m | €12.50 | PS18.7x | E46.3% | n/a | ||
ARGX | €524.20 | 7.4% | 53.3% | €31.9b | €686.01 | PE43.6x | E28.5% | n/a | ||
UCB | €136.30 | 1.2% | 13.6% | €26.3b | €209.78 | PE24.3x | E18.2% | 1.0% | ||
ALEMS | €5.40 | -1.8% | -28.3% | €22.8m | n/a | PE45.7x | n/a | n/a | ||
CYAD | €0.54 | 14.9% | 65.6% | €24.0m | n/a | PS120.3x | n/a | n/a | ||
TUB | €110.20 | 1.8% | 20.0% | €5.0b | €182.75 | PE54.4x | n/a | 0.9% | ||
BIOS | €0.0018 | 0% | -91.2% | €989.4k | n/a | PE-0.1x | n/a | n/a | ||
OXUR | €0.10 | 0.1% | -90.0% | €360.2k | n/a | PE3.1x | n/a | n/a |